28806160|t|Delirium in hospitalized patients: Risks and benefits of antipsychotics.
28806160|a|Consensus panel guidelines advocate for the judicious use of antipsychotic drugs to manage delirium in hospitalized patients when nonpharmacologic measures fail and the patient is in significant distress from symptoms, poses a safety risk to self or others, or is impeding essential aspects of his or her medical care. Here, we review the use of haloperidol, olanzapine, quetiapine, risperidone, and aripiprazole for this purpose.
28806160	0	8	Delirium	Disease	MESH:D003693
28806160	25	33	patients	Species	9606
28806160	164	172	delirium	Disease	MESH:D003693
28806160	189	197	patients	Species	9606
28806160	242	249	patient	Species	9606
28806160	419	430	haloperidol	Chemical	MESH:D006220
28806160	432	442	olanzapine	Chemical	MESH:D000077152
28806160	444	454	quetiapine	Chemical	MESH:D000069348
28806160	456	467	risperidone	Chemical	MESH:D018967
28806160	473	485	aripiprazole	Chemical	MESH:D000068180
28806160	Positive_Correlation	MESH:D000068180	MESH:D003693
28806160	Positive_Correlation	MESH:D000077152	MESH:D003693
28806160	Positive_Correlation	MESH:D000069348	MESH:D003693
28806160	Positive_Correlation	MESH:D018967	MESH:D003693
28806160	Negative_Correlation	MESH:D006220	MESH:D003693

